封面
市場調查報告書
商品編碼
1731959

全球膽紅素儀市場

Bilirubin Meters

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 454 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 2030 年全球膽紅素儀市場規模將達 19 億美元

全球膽紅素測定儀市場規模預計在 2024 年為 13 億美元,預計到 2030 年將達到 19 億美元,在 2024-2030 年分析期內的複合年成長率為 6.8%。台式膽紅素測定儀是報告中分析的細分市場之一,預計其複合年成長率為 7.9%,到分析期結束時將達到 13 億美元。預計分析期間內經皮膽紅素儀部分的複合年成長率為 4.3%。

美國市場規模估計為 3.413 億美元,中國市場預計複合年成長率為 10.8%

預計 2024 年美國膽紅素測定儀市值為 3.413 億美元。預計到 2030 年,作為世界第二大經濟體的中國市場規模將達到 3.896 億美元,2024-2030 年分析期間的複合年成長率為 10.8%。其他值得注意的區域市場包括日本和加拿大,預計在分析期間的複合年成長率分別為 3.3% 和 6.6%。在歐洲,德國的複合年成長率預計為 4.5%。

全球膽紅素計市場-主要趨勢與促進因素摘要

為什麼膽紅素測定儀在新生兒和肝臟健康管理中具有越來越重要的臨床意義?

膽紅素測定儀在臨床診斷中變得越來越重要,特別是在新生兒黃疸和肝臟相關疾病的早期發現和監測。這些設備提供了一種快速、非侵入性或微創的方法來測量血液中的膽紅素濃度或透過經皮篩檢,及時了解肝功能、溶血和代謝清除情況。新生兒高膽紅素血症是新生兒最常見的臨床疾病之一,因此使用膽紅素儀進行早期篩檢對於預防食肉症和膽紅素引起的神經功能障礙(BIND)等併發症至關重要。

除了新生兒護理外,膽紅素儀還用於成人監測肝功能障礙、膽道阻塞和溶血性疾病。結合全球對孕產婦和兒童保健計畫早期療育的重視,人們更加重視照護現場診斷及其在醫院、分娩中心和小兒科門診部的應用。隨著醫療保健提供者尋求即時膽紅素評估工具以減少週轉時間並提高患者吞吐量,這些儀表作為第一線診斷資產變得越來越重要。

技術改進和工作流程整合如何提高膽紅素儀的性能?

膽紅素儀檢測技術的進步提高了測量的準確性、使用者的便利性和診斷的一致性。目前,經皮膽紅素儀採用先進的光強度和多波長光學感測器,以非侵入方式檢測膽紅素濃度,最大限度地減少了對新生兒採血的需求。這些設備旨在針對各種膚色、孕齡和臨床條件提供可重複的測量,以支持其在新生兒加護病房和產後病房的廣泛使用。

手持式可攜式型號配有觸控螢幕介面、自動校準和無線連接功能,可輕鬆整合到電子健康記錄(EHR) 和醫院資訊系統中。其採用電池供電的設計並具有資料登錄功能,增強了其移動性,使其能夠用於農村推廣計劃、門診環境和家庭新生兒監測。製造商還專注於小型化、提高感測器精度以及將膽紅素測量與血紅蛋白和血氧飽和度參數相結合的雙功能模型,擴大其在小兒科和肝病診斷工作流程中的效用。

哪些地方對膽紅素儀的需求增加?哪些醫療環境正在採用膽紅素儀?

北美和歐洲等新興市場的需求最為強勁,這些市場擁有普遍的新生兒篩檢方案和強大的臨床基礎設施,支持黃疸的早期發現。由於高出生率、新生兒護理服務的擴大以及針對周產期併發症的公共衛生努力,亞太地區已成為高成長地區。印度、中國、印尼和越南等國家正在增加公共和私人醫療機構中膽紅素測定儀的採購量,以降低可預防的嬰兒發病率和死亡率。

主要招募集中在新生兒加護病房(NICU)、婦產科醫院及小兒科診所。此外,社區健康計劃和助產網路擴大配備攜帶式膽紅素儀,以便在產後家訪期間進行早期篩檢。在成人醫學中,肝病診所和肝臟移植中心依靠實驗室膽紅素分析儀作為肝功能組診斷的一部分。隨著全球在全民健康覆蓋和農村健康公平方面努力的加強,分散獲得準確的膽紅素監測正在成為診斷能力建設的關鍵組成部分。

推動全球膽紅素測定儀市場成長的因素有哪些?

全球膽紅素測定儀市場的成長受到新生兒護理標準的提高、對母嬰健康的重視以及對延遲檢測黃疸的後果的認知不斷提高的推動。技術創新、對非侵入性篩檢工具的監管支援以及與行動醫療平台的整合,使得這些設備在高資源和低資源醫療保健系統中都更易於存取和擴展。為了更快地進行診斷和干涉,臨床轉向即時床邊檢測也推動了需求。

官民合作關係、透過全球衛生組織進行的捐贈以及政府增加對兒童早期保健計畫的採購正在加速新興經濟體的市場滲透。製造商正在擴大其產品線,推出專為一線醫護人員設計的易於使用、低維護的型號。隨著病患安全、早期療育和分散診斷持續影響醫療保健的優先事項,重要的問題也隨之出現。膽紅素測定儀市場規模是否足夠快,能夠提供非侵入性、高精度的解決方案來支援全球醫療保健生態系統的普遍新生兒篩檢和廣泛的肝功能監測?

部分

產品(台式、經皮)、適應症(黃疸、肝炎)、年齡層(新生兒、成人)、最終用戶(醫院和療養院、診所、其他最終用戶)

受訪企業範例(共34家)

  • Advanced Instruments, LLC
  • Apel Co., Ltd.
  • AVI Healthcare Pvt. Ltd.
  • Danaher Corporation
  • DAS Srl
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Ginevri Srl
  • GPC Medical Ltd.
  • Hadleigh Health Technologies
  • ICEN Technology Company Limited
  • Koninklijke Philips NV
  • Labtron Equipment Ltd.
  • Mennen Medical Ltd.
  • Micro Lab Instruments
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Natus Medical Incorporated
  • Ningbo David Medical Device Co., Ltd.
  • Siemens Healthineers AG
  • Xuzhou Kejian Hi-tech Co., Ltd.

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口(成品和OEM)預測公司競爭地位的變化。這種複雜且多方面的市場動態預計將以多種方式影響競爭對手,包括人為提高銷貨成本、降低盈利、重組供應鏈等微觀和宏觀市場動態。

全球產業分析師密切關注世界領先的首席經濟學家(14,949)、智庫(62)和貿易及產業協會(171)的專家意見,以評估生態系統的影響並應對新的市場現實。各主要國家的專家和經濟學家都在關注關稅及其對國家的影響。

全球產業分析師預計,這種動盪將在未來幾個月內平息,新的世界秩序將更加明確地建立。全球產業分析師正在即時追蹤這些發展。

2025年4月:談判階段

我們四月份的發布將涵蓋關稅對全球市場整體的影響,並為各地區的市場調整提供指導。我們的預測是基於歷史數據和不斷發展的市場影響因素。

2025年7月:最終關稅調整

在各國宣布最終重置後,客戶將於 7 月收到免費更新。最終更新包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析:

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家:全球產業分析師知識庫追蹤 14,949 位經濟學家,其中包括來自民族國家、智庫、貿易和產業協會、大型企業和領域專家的最具影響力的首席經濟學家,他們共用了全球經濟狀況這一前所未有的模式轉移的影響。我們的 16,491 多份報告中的大多數都遵循這個基於兩階段里程碑的發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP33551

Global Bilirubin Meters Market to Reach US$1.9 Billion by 2030

The global market for Bilirubin Meters estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.9 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Benchtop Bilirubin Meters, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Transcutaneous Bilirubin Meters segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$341.3 Million While China is Forecast to Grow at 10.8% CAGR

The Bilirubin Meters market in the U.S. is estimated at US$341.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$389.6 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Bilirubin Meters Market - Key Trends & Drivers Summarized

Why Are Bilirubin Meters Gaining Clinical Importance in Neonatal and Hepatic Health Management?

Bilirubin meters are becoming increasingly essential in clinical diagnostics, particularly for early detection and monitoring of neonatal jaundice and liver-related disorders. These devices offer a rapid, non-invasive or minimally invasive means of measuring bilirubin concentration in blood or through transcutaneous screening-providing timely insight into liver function, hemolysis, and metabolic clearance. As neonatal hyperbilirubinemia remains one of the most common clinical conditions in newborns, early screening using bilirubin meters is critical to preventing complications such as kernicterus and bilirubin-induced neurologic dysfunction (BIND).

In addition to neonatal care, bilirubin meters are being utilized in monitoring hepatic dysfunction, biliary obstruction, and hemolytic diseases in adults. The growing emphasis on point-of-care diagnostics, coupled with the global prioritization of early intervention in maternal and infant health programs, is driving adoption across hospitals, birthing centers, and outpatient pediatric care. As healthcare providers seek real-time bilirubin assessment tools that reduce turnaround times and improve patient throughput, these meters are gaining relevance as frontline diagnostic assets.

How Are Technology Enhancements and Workflow Integration Advancing Bilirubin Meter Performance?

Technological advancements in bilirubin meters are improving measurement accuracy, user convenience, and diagnostic consistency. Transcutaneous bilirubinometers now use advanced spectrophotometry and multi-wavelength optical sensors to detect bilirubin levels non-invasively, minimizing the need for blood draws in neonates. These devices are designed for repeatable measurements across different skin tones, gestational ages, and clinical conditions-supporting widespread adoption in neonatal ICUs and postnatal wards.

Handheld, portable models with touchscreen interfaces, auto-calibration features, and wireless connectivity are facilitating integration into electronic health records (EHRs) and hospital information systems. Battery-operated designs with data logging capabilities enhance mobility and enable use in rural outreach programs, ambulatory settings, and home-based newborn monitoring. Manufacturers are also focusing on miniaturization, sensor precision, and dual-function models that combine bilirubin measurement with hemoglobin or oxygen saturation parameters-broadening their utility within pediatric and hepatic diagnostic workflows.

Where Is Demand for Bilirubin Meters Rising and Which Care Settings Are Driving Adoption?

Demand is strongest in developed markets such as North America and Europe, where universal newborn screening protocols and robust clinical infrastructure support early jaundice detection. Asia-Pacific is emerging as a high-growth region due to high birth rates, expanding neonatal care access, and public health initiatives targeting perinatal complications. Countries such as India, China, Indonesia, and Vietnam are witnessing increased procurement of bilirubin meters in both public and private healthcare facilities to reduce preventable infant morbidity and mortality.

Primary adoption is concentrated in neonatal intensive care units (NICUs), maternity hospitals, and pediatric clinics. Community health programs and midwifery networks are also increasingly equipped with portable bilirubinometers for early screening during postnatal home visits. In adult medicine, hepatology clinics and liver transplant centers rely on lab-based bilirubin analyzers as part of liver function panel diagnostics. With global efforts intensifying around universal health coverage and rural health equity, decentralized access to accurate bilirubin monitoring is becoming a critical component of diagnostic capacity-building.

What Is Fueling the Global Growth of the Bilirubin Meters Market?

The global growth of the bilirubin meters market is being driven by rising neonatal care standards, the prioritization of maternal and child health, and growing awareness of the consequences of delayed jaundice detection. Technological innovation, regulatory support for non-invasive screening tools, and integration with mobile health platforms are making these devices more accessible and scalable across both high- and low-resource healthcare systems. Demand is also reinforced by the clinical shift toward real-time, bedside testing for faster diagnosis and intervention.

Public-private partnerships, donations through global health organizations, and increased government procurement under infant health programs are accelerating market penetration in emerging economies. Manufacturers are expanding product lines with user-friendly, maintenance-light models designed for frontline health workers. As patient safety, early intervention, and diagnostic decentralization continue to shape healthcare priorities, a critical question emerges: Can the bilirubin meter market scale non-invasive, high-accuracy solutions fast enough to support universal newborn screening and broader hepatic health surveillance across global care ecosystems?

SCOPE OF STUDY:

The report analyzes the Bilirubin Meters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Benchtop, Transcutaneous); Indication (Jaundice, Hepatitis); Age Group (Neonatal, Adults); End-User (Hospitals & Nursing Homes, Clinics, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Advanced Instruments, LLC
  • Apel Co., Ltd.
  • AVI Healthcare Pvt. Ltd.
  • Danaher Corporation
  • DAS Srl
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Ginevri Srl
  • GPC Medical Ltd.
  • Hadleigh Health Technologies
  • ICEN Technology Company Limited
  • Koninklijke Philips N.V.
  • Labtron Equipment Ltd.
  • Mennen Medical Ltd.
  • Micro Lab Instruments
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Natus Medical Incorporated
  • Ningbo David Medical Device Co., Ltd.
  • Siemens Healthineers AG
  • Xuzhou Kejian Hi-tech Co., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bilirubin Meters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Neonatal Jaundice Drives Global Demand for Point-of-Care Bilirubin Meters
    • Non-Invasive Transcutaneous Meters Gain Preference in Pediatric and Maternity Care Settings
    • Real-Time Bilirubin Monitoring Enhances Early Intervention and Reduces Hospital Readmission
    • Integration With EHRs and Smart Monitoring Platforms Increases Clinical Workflow Efficiency
    • Portable and Handheld Devices Expand Bilirubin Testing in Low-Resource and Rural Healthcare Environments
    • Calibration Accuracy and Phototherapy Threshold Alerts Strengthen Utility in NICU Applications
    • Growth in Home-Based Newborn Care and Midwife Services Increases Use of Compact Bilirubin Meters
    • Regulatory Approvals and Safety Certifications Influence Vendor Selection in Pediatric Units
    • Multi-Parameter Devices Combining Jaundice and Vital Monitoring Improve Adoption in Newborn Bundles
    • Technology Advancements in Optical Sensors Improve Diagnostic Speed and Reliability
    • Public Health Initiatives for Infant Screening Expand Access to Bilirubin Testing in Developing Regions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bilirubin Meters Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bilirubin Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Benchtop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Benchtop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Benchtop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Transcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Transcutaneous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Jaundice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Jaundice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Jaundice by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hepatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hepatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hepatitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Neonatal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Neonatal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Neonatal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Adults by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Nursing Homes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Nursing Homes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals & Nursing Homes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • JAPAN
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • CHINA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • EUROPE
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Bilirubin Meters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • FRANCE
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • GERMANY
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 131: UK Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 134: UK Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 143: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Spain Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Spain 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 155: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Russia Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Russia 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Europe 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Bilirubin Meters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 194: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Australia Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Australia 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Australia 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • INDIA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 206: India Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: India Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: India 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 209: India Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: India 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 218: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: South Korea Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: South Korea 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: South Korea 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 230: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Asia-Pacific Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 242: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Latin America Historic Review for Bilirubin Meters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Latin America 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Latin America 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 257: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Argentina Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Argentina 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Argentina 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 269: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Brazil Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Brazil 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Brazil 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 281: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Mexico Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Mexico 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Mexico 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 293: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Latin America Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Latin America 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Latin America 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 305: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 306: Middle East Historic Review for Bilirubin Meters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Middle East 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Middle East 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 320: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Iran Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Iran 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Iran 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 332: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Israel Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Israel 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Israel 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 344: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Saudi Arabia Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Saudi Arabia 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Saudi Arabia 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 356: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: UAE Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: UAE 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: UAE 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 368: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Rest of Middle East Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: Rest of Middle East 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Middle East 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • AFRICA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 380: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Africa Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Africa 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Africa 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION